Oculos is a vertically integrated ophthalmic R&D organization serving the pharmaceutical, biotech, medical device and diagnostic industries. We exist to improve the quality of life for patients and consumers by supporting the research, development and clinical testing of life-enhancing ophthalmic products. We consistently exceed our clients’ expectations through our strategic leadership, quality science, operational excellence and years of experience in the ophthalmic space.
In July 2018, Oculos Clinical Research was acquired by iuvo BioScience. iuvo maintains a 30,000-square-foot preclinical laboratory testing facility outside of Rochester, NY that offers an on-site AAALAC-accredited vivarium and specialty testing services for the medical device and pharmaceutical industries. iuvo has an experienced team whose breadth of expertise spans multiple disciplines including Analytical Chemistry, Microbiology, Toxicology and Sterilization within the medical device and pharmaceutical industries. iuvo is particularly experienced in the ophthalmic industry, developing and launching OTC, drug, device and combination products.
The establishment of Oculos as a vertically integrated ophthalmic R&D service provider takes service beyond a typical CRO, by providing a PRO™ (Partner Research Organization) to work with you throughout your development program.